Displaying items by tag: Perrigo Co plc

Sunday, 21 June 2020 09:14

MiBiz Growth Report: June 21, 2020

Here is the MiBiz  Growth Report for June 21, 2020.

Published in Economic Development

Perrigo Co. plc has sold its generic prescription drug business to United Kingdom-based Rosemont Pharmaceuticals Ltd for $195 million in cash.

Published in Health Care

Perrigo Co. plc plans to enter the CBD market through a strategic investment and a long-term agreement with a Colorado supplier.

Published in Food/Agribusiness

ALLEGAN — Higher consumer demand to treat symptoms of COVID-19 pushed Perrigo Co. plc to a 14-percent increase in sales growth for the first quarter.

Published in Health Care

ALLEGAN — Perrigo Co. plc recorded strong double-digit sales growth for the first quarter, as demand spiked for over-the-counter medications in March in the COVID-19 pandemic.

Published in Health Care
Sunday, 01 March 2020 10:06

MiBiz growth report: March 1, 2020

Here is the MiBiz growth report for March 1, 2020.

Published in Economic Development

ALLEGAN — Perrigo Co. plc “hit on all cylinders” in the fourth quarter as sales growth picked up toward the end of 2019.

Published in Health Care

ALLEGAN — Perrigo Co. plc plans to buy the oral product line from Stamford, Conn.-based High Ridge Brands Inc., which filed for bankruptcy in December.

Published in Health Care

ALLEGAN — The transformation plan President and CEO Murray Kessler put in place last spring to return Perrigo Co. plc to revenue and earnings growth appears to have gained traction late in 2019, based on preliminary results for the fourth quarter.

Published in Health Care
Saturday, 18 January 2020 13:20

Growth Report: January 18, 2020

This is the growth report for January 18, 2020.

Published in Economic Development
Page 1 of 6